Noom Med

Medications offered

As listed on the provider’s own site. Whether a product is FDA-approved or compounded is the single most important distinction here — we explain why.

• GLP-1 medication (programme tiers)Type not stated
• Low-dose semaglutide (microdose programme)Type not stated
• Low-dose tirzepatide (microdose programme)Type not stated

What they publish

Noom Med publishes 3 of 12 standard terms. Fields marked “not publicly disclosed” were not stated on the pages we captured, and we have not filled those gaps with assumptions. Compare disclosure across providers

Membership / programme fee

Noom Weight published at $17.42/month on a 12-month plan, with a 7-day trial and cancel-any-time (as published)

Medication cost

GLP-1 tiers published starting at $129 and $149/month with medication included and no insurance needed; a separate tier at $39 to get started with medication not included; microdose programmes from $49 (semaglutide) and $79 (tirzepatide) (as published)

Introductory offer

$39 initial 30-day trial on one tier (medication not included)

Insurance

Not publicly disclosed on the pages we captured.

HSA / FSA

Not publicly disclosed on the pages we captured.

Consultation process

Not publicly disclosed on the pages we captured.

Eligibility

Not publicly disclosed on the pages we captured.

Lab work

Not publicly disclosed on the pages we captured.

Pharmacy fulfilment

Not publicly disclosed on the pages we captured.

Shipping

Not publicly disclosed on the pages we captured.

Support services

Not publicly disclosed on the pages we captured.

Cancellation

States the behavioural plan offers a 7-day trial and can be cancelled at any time.

Refunds

Not publicly disclosed on the pages we captured.

What stands out

• Several tiers include the medication in the monthly price, which is unusual and makes comparison against membership-only competitors much easier.
• Offers a 'microdose' programme at lower published prices. Microdosing is not an FDA-approved regimen and is worth discussing with a clinician who is not selling it.
• The published pages did not state whether the GLP-1 medication supplied is FDA-approved or compounded, which for the price is the first thing to establish.

Questions to ask before you pay

These are things we could not settle from published pages, or that we think are easy to misread. Get answers in writing.

• Establish whether the medication in your tier is FDA-approved or compounded before paying — the pages we captured did not say.
• The $17.42 figure is the behavioural app on an annual plan, not the medication programme. Do not confuse the two.
• Ask what the microdose programme actually delivers relative to a standard titration.

Frequently asked